Clinical Trial Update: Extension Study of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia [Phase 3]

View source ↗

Summary

Extension Phase 3 study of vibegron for overactive bladder in men on BPH therapy has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia
• Overactive Bladder

Drugs mentioned

• Vibegron (vibegron)

Snippet

Sponsor: Urovant Sciences GmbH | Conditions: Overactive Bladder | Phase 3 | Status: COMPLETED | Results posted: 2024-08-21